Fortitude Family Office »

Quince Therapeutics shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Quince Therapeutics shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Quince Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Quince Therapeutics held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quince Therapeutics by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2026-03-31 $820 8.1k 0.10

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Avantis Total Equity Markets Etf Etf (AVTM)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Apple Stock (AAPL)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Mid-cap Etf Etf (VO)
Vanguard S&p 500 Etf Etf (VOO)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Invesco Senior Loan Etf Etf (BKLN)
Avantis International Small Cap Value Etf Etf (AVDV)

View all positions for Fortitude Family Office

Top funds holding Quince Therapeutics

Tudor Investment Corporation
Gen-Wealth Partners
Catalyst Funds Management Pty
Fortitude Family Office
Parallel Advisors
SBI Securities

View all funds holding Quince Therapeutics